🫀Associate Program Director @LaheyCardiology | Assistant Professor @UmassChan | via @BidmcCVI @Stanfordmed | momx2, wife👩🏻🍼👩🏻❤️👨🏻
Joined May 2019
- Tweets 1,063
- Following 338
- Followers 1,248
- Likes 2,544
49 Photos and videos
Pinned Tweet
4 Sep 2021
🫀For all the cardiology fellows starting call, I wanted to share this #ECGchallenge published in @JACCJournals #JACCCaseReports #tweetorial
27-year-old woman presented with palpitations. What does her ECG show?
30
197
665
Inbar McCarthy MD FACC retweeted
Masterclass on Genetic Dilated Cardiomyopathy by superb @noshreza @bethisraellahey @LaheyResearch @LaheyHospital today! Fabulous talk on how #GeneFirst approach is valuable in caring for patients with DCM!
1
6
50
6,813
Inbar McCarthy MD FACC retweeted
Mar 18
The 2026 ACC/AHA Multisociety #Dyslipidemia Guideline-at-a-Glance offers a visual summary of key updates in CV risk assessment, lipid treatment goals, & #ASCVD risk reduction.
A quick reference for clinicians: jacc.org/doi/10.1016/j.jacc.…
#JACC #ClinicalGuidelines #cvLipids
1
49
133
9,666
Inbar McCarthy MD FACC retweeted
The 2026 ACC/AHA/Multisociety Guideline for the Management of Dyslipidemia now includes new infographics and tables designed for quick reference and to make key information easier to understand.
As you review the updated guideline, don’t forget to save these helpful visuals for later!
Read the guidelines: ow.ly/ZhSV50Ywze4
#Lipidology #Dyslipidemia #Cholesterol #CardiovascularHealth
24
51
4,099
Inbar McCarthy MD FACC retweeted
Mar 13
Honored to contribute to the 2026 ACC/AHA Dyslipidemia Guidelines - out now! Indebted to @rblument1 & @PamelaBMorris for their expert leadership and stewardship.
Major themes:
- earlier prevention
- more personalized risk assessment
- lower LDL-C targets
@AHAScience @AHAScience
[1/14] 🧵
Mar 13
Key updates to this guideline include:
➡️ The use of the American Heart Association PREVENT-ASCVD equations to guide primary-prevention and lipid-lowering therapy decisions.
➡️ Testing Lp(a) at least once in a lifetime and selective apolipoprotein B measurement to improve risk assessment and guide treatment
➡️ The return of LDL-C and non-high-density lipoprotein cholesterol treatment goals (with lower targets for higher-risk groups)
➡️ Expanded use of coronary artery calcium scoring to reclassify risk[ME1.1]
✍🏼 @rblument1 @tygluckman @RonBlankstein @PamelaBMorris @pnatarajanmd @AnnMarieNavar @SethShayMartin @APRN_CNS @nyulangone @DrMichaelShapir @kgradneyrd @eugeniagianos @virani_md @KellieMcLain1 @ijeomaheartdoc @SamiaMoraMD @DrHeatherJohn @dmljmd
5
53
198
49,125
Inbar McCarthy MD FACC retweeted
Mar 13
Key updates to this guideline include:
➡️ The use of the American Heart Association PREVENT-ASCVD equations to guide primary-prevention and lipid-lowering therapy decisions.
➡️ Testing Lp(a) at least once in a lifetime and selective apolipoprotein B measurement to improve risk assessment and guide treatment
➡️ The return of LDL-C and non-high-density lipoprotein cholesterol treatment goals (with lower targets for higher-risk groups)
➡️ Expanded use of coronary artery calcium scoring to reclassify risk[ME1.1]
✍🏼 @rblument1 @tygluckman @RonBlankstein @PamelaBMorris @pnatarajanmd @AnnMarieNavar @SethShayMartin @APRN_CNS @nyulangone @DrMichaelShapir @kgradneyrd @eugeniagianos @virani_md @KellieMcLain1 @ijeomaheartdoc @SamiaMoraMD @DrHeatherJohn @dmljmd
9
148
329
115,725
Inbar McCarthy MD FACC retweeted
31 Dec 2025
Here are my top book title picks from 2025.
1
1
75
Inbar McCarthy MD FACC retweeted
14 Dec 2025
On this first night of Hanukkah, Michelle and I are praying for the families mourning a loved one after the horrific terrorist attack against Jewish people in Australia. For everyone lighting a candle tonight, may the glow of the menorah brighten your darkest moments. Chag Sameach from our family to yours.
8,122
14,170
198,033
35,483,226
Inbar McCarthy MD FACC retweeted
3 Dec 2025
Lots of confusion about menopausal hormone therapy right now —who should get it, when to start, and what is the🫀 risk?
Our new review led by @BrighamMedRes Ruby Guo covers timing, route, and CV risk stratification for midlife women.
🔗: rdcu.be/eSUqJ
11
71
220
27,891
Inbar McCarthy MD FACC retweeted
Fantastic match results! Could not be happier to get the phenomenal group at Lahey Cardiology for 2026!
6
10
160
26,965
4 Dec 2025
Welcome to @LaheyHospital we are truly so excited to work this inspiring group of soon to be cardiology fellows. The future of CV medicine is bright with the current and future fellows, and amazing PD Saurabh Dani. 🫀🌟
Fantastic match results! Could not be happier to get the phenomenal group at Lahey Cardiology for 2026!
3
24
4,576
Inbar McCarthy MD FACC retweeted
7 Sep 2025
To accompany the new ACC/AHA BP guidelines, a practical guide on how to test for Primary Aldosteronism: now recommended for most people with hypertension.
jacc.org/doi/10.1016/j.jacc.…
4
92
265
28,201
Inbar McCarthy MD FACC retweeted
4 Sep 2025
#DIGITHF "A Renaissance for Cardiac Glycosides"
Bravo @JBauersachsMD👏🏾
Shape of KM curve reflecting:
- Long enrollment '15-'23 (all curves converge eventually!)
- High risk cohort (NYHA III/IV)
- High study drug discontinuation (~55%)
- Few pts studied beyond 5y
#ESCCongress
2
6
39
3,019
Inbar McCarthy MD FACC retweeted
5 Sep 2025
#BaxHTN A New Drug for Resistant or Uncontrolled Hypertension
✅ 9-10mmHg early SBP lowering on background Rx, even w lower doses (1mg)
✅ Remarkably ongoing BP effects & aldo suppression 8wks after withdrawal
✅ ASIs actively being studied in HF prevention, HFrEF, HFpEF, & CKD
2
16
63
4,198
Inbar McCarthy MD FACC retweeted
3 Sep 2025
The AQUATIC trial may be the most definitive trial of #ESCCOngress
The common combo of ASA and OAC for pts with CAD/stent and AF is clearly been harming people. Lots.
MACE worse, Death worse, Bleeding way worse.
STOP THE ASA when on OAC
nejm.org/doi/full/10.1056/NE…
11
129
397
38,786
Inbar McCarthy MD FACC retweeted
1 Sep 2025
When will any meeting have the King come to our meetings to thank us for the work! With an addition of a shout out to Prevention #CVPrev
#ESCCongress @escardio
2
11
95
8,059
1 Sep 2025
For patients with resistant or difficult to control HTN, baxdrostat, an Aldosterone synthase inhibitor had a 10 mmHG blood pressure drop at 12 weeks 4/4 nejm.org/doi/full/10.1056/NE…
1
158
Inbar McCarthy MD FACC retweeted
30 Aug 2025
POTCAST RCT
📌 In 👫 with #ICD, a strategy to ⬆️ plasma #potassium levels to the high-normal range by means of potassium 💊supplementation or mineralocorticoid receptor antagonist 💊 administration
👉 ⬇️ risk of #VentricularArrhythmias
#EPeeps #CardioTwitter #MedTwitter #SCD
2
4
12
1,320